FERRING B.V. v. MYLAN, INC. et al
FERRING B.V. |
MYLAN PHARAMACEUTICALS, INC., MYLAN, INC. and MYLAN INSTITUTIONAL |
2:2013cv05909 |
October 7, 2013 |
US District Court for the Eastern District of Pennsylvania |
Philadelphia Office |
Outside the State of PA. |
ROBERT F. KELLY |
Patent |
15 U.S.C. ยง 1126 |
None |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 71 ORDERED THAT THE FOLLOWING CLAIM CONSTRUCTION IS ADOPTED: THE CLAIM TERM "MODIFIED RELEASE MATERIAL" IS TO BE CONSTRUED TO MEAN "A MATERIAL THAT MODIFIES THE RELEASE OF THE ACTIVE PHARMACEUTICAL INGREDIENT." SIGNED BY HONORABLE ROBERT F. KELLY ON 11/25/2014. 11/25/2014 ENTERED AND COPIES E-MAILED.(sg, ) |
Filing 58 ORDERED THAT MYLAN PHARMACEUTICALS INC.'S MOTION TO TRANSFER THIS ACTION IS DENIED. IT IS FURTHER ORDERED THAT PLAINTIFF'S REQUEST FOR ITS COSTS AND FEES IN CONNECTION WITH THIS MOTION IS DENIED. ADDITIONALLY, THE PARTIES' REQUESTS FOR ORAL ARGUMENT ARE DENIED. SIGNED BY HONORABLE ROBERT F. KELLY ON 8/21/2014. 8/21/2014 ENTERED AND COPIES E-MAILED.(sg, ) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Pennsylvania Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.